Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism

JAMA Neurology

Volumn 70, Issue 7, 2013, Pages 859-866

  Savica, Rodolfo ^a,c   Grossardt, Brandon R ^b   Bower, James H ^b   Ahlskog, J Eric ^a   Rocca, Walter A ^a,b  

^a Department of Health Sciences Research   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SYNUCLEIN; TAU PROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; CHILD; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARKINSONISM; PATHOLOGY; PATIENT IDENTIFICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SCHOOL CHILD; SEX DIFFERENCE; SYNUCLEINOPATHY; TAUOPATHY; UNITED STATES;

EID: 84880302934     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.114     Document Type: Article

References (42)

1. Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G. Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord. 2011;26(12):2286-2290.
2. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord. 2003;18(1):19-31.
3. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525-535.
4. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015-1022.
5. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology. 1997;49(5):1284-1288.
6. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999;52(6):1214-1220.
7. Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of α-synuclein and its aggregates. J Neurosci. 2005;25(25):6016-6024.
8. Jellinger KA. Formation and development of Lewy pathology: a critical update. J Neurol. 2009;256(suppl 3):270-279.
9. Williams DR. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J. 2006;36(10):652-660.
10. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ III, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2):151-160.
11. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ III, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011;173(9):1059-1068.
12. RoccaWA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ III. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc. 2012;87(12):1202-1213.
13. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012;41(6):1614-1624.
14. Commission on Professional and Hospital Activities, National Center for Health Statistics. H-ICDA: Hospital Adaptation of International Classification of Disease, Eighth Revision. 2nd ed. Ann Arbor, MI: Commission on Professional and Hospital Activities; 1973.
15. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland:World Health Organization; 1977.
16. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB InternationalWorkshop. J Alzheimers Dis. 2006;9(3)(suppl):417-423.
17. Gilman S, Low P, Quinn N, et al; American Autonomic Society and American Academy of Neurology. Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res. 1998;8(6):359-362.
18. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry. 1995;58(2):167-173.
19. Boeve BF. Corticobasal degeneration: the syndrome and the disease. In: Litvan I, ed. Current Clinical Neurology: Atypical Pakinsonian Disorders. Totowa, NJ: Humana Press Inc; 2005:309-333.
20. Maraganore DM, Ahlskog JE, Peterson RT. Progressive asymmetric rigidity with apraxia: a distinct clinical entity [abstract]. Mov Disord. 1992;7:80.
21. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
22. de Rijk MC, Tzourio C, Breteler MM, et al; EUROPARKINSON Study Group. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. J Neurol Neurosurg Psychiatry. 1997;62(1):10-15.
23. Anderson DW, Mantel N. On epidemiologic surveys. Am J Epidemiol. 1983;118(5):613-619.
24. Boeve BF, Boylan KB, Graff-Radford NR, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135(pt 3):765-783.
25. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142(8):820-827.
26. Haaxma CA, Bloem BR, Borm GF, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78(8):819-824.
27. Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984;16(3):278-282.
28. Baldereschi M, Di Carlo A, RoccaWA, et al; ILSA Working Group. Italian Longitudinal Study on Aging. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Neurology. 2000;55(9):1358-1363.
29. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry. 2004;75(4):637-639.
30. Taylor KSM, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2007;78(8):905-906.
31. Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM. Gender differences in Parkinson's disease symptom profile. Acta Neurol Scand. 2000;102(1):37-43.
32. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Risk factors for Parkinson's disease may differ in men and women: an exploratory study [published online June 8, 2012]. Horm Behav. doi:10. 1016/j. yhbeh. 2012. 05. 013.
33. Saunders-Pullman R, Stanley K, San Luciano M, et al. Gender differences in the risk of familial parkinsonism: beyond LRRK2? Neurosci Lett. 2011;496(2):125-128.
34. Chung SJ, Armasu SM, Biernacka JM, et al. Variants in estrogen-related genes and risk of Parkinson's disease. Mov Disord. 2011;26(7):1234-1242.
35. Frigerio R, Sanft KR, Grossardt BR, et al. Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord. 2006;21(10):1688-1692.
36. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Influence of strict, intermediate, and broad diagnostic criteria on the age-and sex-specific incidence of Parkinson's disease. Mov Disord. 2000;15(5):819-825.
37. RoccaWA, Bower JH, McDonnell SK, Peterson BJ, Maraganore DM. Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology. 2001;57(3):462-467.
38. Elbaz A, Bower JH, Maraganore DM, et al. Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol. 2002;55(1):25-31.
39. Bower JH, Dickson DW, Taylor L, Maraganore DM, Rocca WA. Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov Disord. 2002;17(5):910-916.
40. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50(2):140-148.
41. Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nat Rev Neurol. 2009;5(12):649-658.
42. Oinas M, Sulkava R, Polvikoski T, Kalimo H, Paetau A. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology. APMIS. 2007;115(7):820-827. Health